What is Iasis Molecular Sciences?
Iasis Molecular Sciences operates at the forefront of molecular science, dedicated to pioneering advancements and delivering novel solutions. The company's product portfolio features innovations such as IONCLAD antimicrobials, designed to offer advanced protection. Targeting organizations and individuals seeking state-of-the-art scientific applications, Iasis Molecular Sciences emphasizes collaboration and innovation within the scientific community. Its commitment to research and development positions it as a key player in the molecular science sector.
How much funding has Iasis Molecular Sciences raised?
Iasis Molecular Sciences has raised a total of $46K across 1 funding round:
Debt
$46K
Debt (2021): $46K with participation from PPP
What's next for Iasis Molecular Sciences?
With the recent influx of expansion capital, Iasis Molecular Sciences is poised for significant growth and further development of its innovative product lines. The company's strategic focus on fostering collaborations and driving scientific advancement suggests a trajectory aimed at broadening its market reach and enhancing its technological capabilities. This latest round of financing is expected to fuel R&D initiatives, scale production of its proprietary solutions like IONCLAD antimicrobials, and solidify its position as a leader in molecular science.
See full Iasis Molecular Sciences company page
